Depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents: what is next after the FDA black box warning

J Pediatr Adolesc Gynecol. 2005 Jun;18(3):183. doi: 10.1016/j.jpag.2005.03.007.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adolescent
  • Bone Density / drug effects*
  • Contraceptives, Oral, Synthetic / administration & dosage
  • Contraceptives, Oral, Synthetic / adverse effects*
  • Delayed-Action Preparations
  • Female
  • Humans
  • Medroxyprogesterone Acetate / administration & dosage
  • Medroxyprogesterone Acetate / adverse effects*
  • Osteoporosis / chemically induced

Substances

  • Contraceptives, Oral, Synthetic
  • Delayed-Action Preparations
  • Medroxyprogesterone Acetate